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Abstract
Background: Venous leg ulcers can be very hard to heal and represent a significant medical need with no effective
therapeutic treatment currently available.
Principal Findings: In wound edge biopsies from human venous leg ulcers we found a striking upregulation of dermal N-
cadherin, Zonula Occludens-1 and the gap junction protein Connexin43 (Cx43) compared to intact skin, and in stark
contrast to the down-regulation of Cx43 expression seen in acute, healing wounds. We targeted the expression of these
proteins in 3T3 fibroblasts to evaluate their role in venous leg ulcers healing. Knockdown of Cx43 and N-cadherin, but not
Zonula Occludens-1, accelerated cell migration in a scratch wound-healing assay. Reducing Cx43 increased Golgi
reorientation, whilst decreasing cell adhesion and proliferation. Furthermore, Connexin43 and N-cadherin knockdown led to
profound effects on fibroblast cytoskeletal dynamics after scratch-wounding. The cells exhibited longer lamelipodial
protrusions lacking the F-actin belt seen at the leading edge in wounded control cells. This phenotype was accompanied by
augmented activation of Rac-1 and RhoA GTPases, as revealed by Fo ¨rster Resonance Energy Transfer and pull down
experiments.
Conclusions: Cx43 and N-cadherin are potential therapeutic targets in the promotion of healing of venous leg ulcers, by
acting at least in part through distinct contributions of cell adhesion, migration, proliferation and cytoskeletal dynamics.
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Introduction
Chronic wounds, such as diabetic foot ulcers, pressure ulcers,
and venous leg ulcers (VLU) are an increasing problem worldwide,
with estimates that 1–2% of the population in Western countries
will develop a chronic wound over the course of their lifetime [1].
Chronic wounds represent a major economic burden on
healthcare services with an estimated annual USA expenditure
of $25 billion [2,3]. With the growing numbers of elderly and
diabetics in the population this expenditure figure is expected to
rise in coming years. Unfortunately there is little in the way of
effective therapeutic options for these debilitating wounds and
there remains a significant need for effective new treatments.
Cx43 is the most ubiquitous connexin in the skin, expressed in
keratinocytes and fibroblasts, endothelial cells and dermal
appendages [4,5]. We have reported that topical application of
a Cx43-specific antisense containing gel to acute wounds in rodent
models significantly accelerates the healing process whilst reducing
inflammation and scar size [6,7].
In the normal healing process Cx43 protein becomes down-
regulated in keratinocytes in the first 24–48 hours as they become
migratory and crawl forward to close the wound [8,9,10,11,12].
Following experiments in Cx43 conditional knockout mice it was
later reported that downregulation of Cx43 appears to be a pre-
requisite for the coordinated proliferation and mobilization of
keratinocytesduringwoundhealing[13,14].Incontrast,weshowed
that in STZ diabetic rats, a model for chronic wounds, Cx43 is
upregulated in wound edge keratinocytes instead of being down-
regulated,andthatmigrationisdelayeduntildownregulationoccurs
[15]. Application of a Cx43 antisense to STZ diabetic rat wounds
prevented the abnormal upregulation of Cx43 and restored wound
closure to normal rates or better [15]. Over-expression of Cx43 was
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37374also shown to inhibit corneal endothelial wound healing in an in vivo
rat corneal scrape injury model, while knockdown with Cx43
antisense sped it up [16]. Cx43 was also reported to be detected in
thecellsatthewoundmarginsofthemajorityofbiopsiestakenfrom
nine mixed and two diabetic leg ulcers [11].
One of the key impediments to the healing of chronic wounds is
the failure of fibroblasts to migrate, proliferate and generate
granulation tissue. Most previous reports have concentrated on
epidermal Cx43 in wound healing and little attention has been paid
to Cx43 in dermal fibroblasts. In the present work, we used
acombinationofinvivoandinvitromodelstoanalyzetheimplications
of elevated Cx43 expression, which we have discovered to be
detrimentally upregulated in the dermis of human chronic VLU,
andtocorrelatewithreducedratesofmigrationofscratch-wounded
fibroblasts over-expressing Cx43. In addition to Cx43, we also
discovered that ZO-1 and N-cadherin, which interact with Cx43
and each other [17], are abnormally overexpressed in the dermis of
humanchronicVLU.TargetingCx43reducedtheexpressionlevels
of ZO-1 and N-cadherin both in vitro and in vivo. Knock down of
Cx43 and N-cadherin, but not ZO-1, accelerated cell migration in
a scratch wound-healing assay. Reduction of Cx43 or N-cadherin
also increased Golgi polarization whilst reducing proliferation and
cell adhesion in fibroblasts. Targeting of Cx43 or N-cadherin,
furthermore, was accompanied by cytoskeletal changes, increased
lamellipodia protrusion, and activation of Rho GTPases. These
findings support the idea that Cx43and N-cadherin are therapeutic
targets for improvement of wound repair through a mechanism
involving remodeling of cell contacts and adhesion-dependent
cytoskeletal modifications in fibroblasts.
Results
Cx43, N-cadherin and ZO-1 are dramatically upregulated
in the dermis of human VLU
Skin punch biopsies, 2 mm, from healthy human volunteers
(Figure 1A), and chronic wound edge biopsy samples, 4 mm, from
6 human VLU (Figure 1D and E), together with corresponding
intact skin samples from the same patients (Figure 1E), were used
to analyze Cx43 protein levels in the dermis of chronic vs. acute
wounds. In acute wounds, downregulation of Cx43 was seen at
dermal wound margins 4 hours after excisional wounding
(Figure 1A), similar to that observed in the wound-edge dermis
in a murine model after an excisional wounding (Figure S1, A)
while Cx43 has been reported to persist at the wound edge
epidermis of a majority of mixed diabetic leg ulcers [11]. Human
and murine skin punch biopsies analysis showed that Cx43 was
significantly reduced at the wound edge, with levels increasing
towards normal with progressive distance from the injury site
(Figure 1, A, B and C; p,0.01; and Figure S1, A, arrowheads;
p,0.005). In sharp contrast, biopsies from the wound edge of
VLU had not only failed to downregulate Cx43, but also showed
significantly elevated expression of Cx43 throughout the dermis of
the whole 4 mm biopsy (Figure 1, E and F; p,0.005).
Cx43 can interact with adherens junction proteins such as N-
cadherin [17,18], and with the tight junction associated protein
ZO-1 [19] which also interact with each other. We investigated
the expression and distribution of these proteins in the dermis of
chronic VLU biopsies and matched non-wounded skin (Figure 2,
A and B). ZO-1 and N-cadherin levels were significantly higher in
chronic VLU samples than in matched non-wounded control
dermis (Figure 2, C and D; p,0.01 and p,0.005, respectively).
Taken together, these data indicate that human chronic VLUs not
only fail to downregulate Cx43 in the dermal wound margins, but
also that N-cadherin and ZO-1 are abnormally upregulated
compared to their levels in intact skin.
Cx43 expression is tightly linked to N-cadherin and ZO-1
expression in fibroblasts
We have previously shown that Cx43 downregulation signifi-
cantly accelerates the skin healing process [6,7]. Here we
investigated the effects of Cx43 knockdown on ZO-1 and N-
cadherin protein expression in vivo. To this end we used a mouse
model of wound healing where full thickness skin excision wounds
were treated with Cx43 antisense, or sense oligodeoxynucleotide
control (Cx43asODN and Cx43sODN, respectively).
Immunohistochemical analysis revealed positive ZO-1 staining
in dermal sense-treated wounds, where ZO-1 was frequently co-
localized with Cx43 (Figure S1, B). Treatments with Cx43asODN,
on the other hand, induced a significant decline not only of Cx43,
but also of ZO-1 in the dermal wound margins (Figure S1, B;
Figure 3A, p,0.05). Analysis of N-cadherin expression revealed
a preferential distribution in the dermis in sense-treated wounds,
and significant protein downregulation after treatment with the
Cx43asODN (Figure S1, C; Figure 3B, p,0.01). These data
demonstrate that Cx43 expression is tightly linked to ZO-1 and N-
cadherin expression in the dermis, and that targeting Cx43 can
reduce ZO-1 and N-cadherin expression in vivo.
In order to better understand the effects of Cx43, N-cadherin
and ZO-1 on fibroblast migration in response to a wounding
stimulus we turned to the 3T3 fibroblast cell line. This can be
easily transfected or transduced with shRNA constructs and avoids
the variability of primary human fibroblasts derived from different
patients. ZO-1 and N-cadherin expression was evaluated in
fibroblasts transduced with a Cx43 short-hairpin RNA
(Cx43shRNA) that suppresses Cx43 expression [20], or a p.Sup
control plasmid. Cx43 protein expression and gap junction-
mediated intercellular communication (GJIC) were effectively
prevented in the Cx43shRNA cells, in contrast to p.Sup control
cells (Figure 3C; Figure S2, G and I). With regard to ZO-1
expression, ZO-1 protein levels were downregulated in
Cx43shRNA-transduced cells (Figure 3D). ZO-1 distribution was
also analyzed in fibroblast scratch wound assays generated with
Cx43shRNA and control cells. The Cx43shRNA-transduced cells
showed a reduction of ZO-1 located at cell contacts at both the
leading edge (LE) and in regions more internal to the wound (IA),
accompanied by a loss of ZO-1 from the leading edge lamellipodia
(Figure 3E, arrowheads). In p.Sup-transduced fibroblasts, howev-
er, ZO-1 was predominantly restricted to the contact margins
between cells, often co-localizing with Cx43 (Figure 3E). With
regard to N-cadherin, protein levels were significantly reduced in
Cx43shRNA-transduced fibroblasts (Figure 3F; p,0.01) and N-
cadherin was found located predominantly in the cytosol
(Figure 3G, arrows) rather than the preferential plasma membrane
localization found in p.Sup-transduced control fibroblasts
(Figure 3G, arrowheads).
We also studied a- and b-catenin expression and distribution in
p.Sup and Cx43shRNA-transduced cells. Whereas total b-catenin
protein levels did not change significantly after Cx43 knockdown
(Figure S3B), its cellular distribution was altered. In p.Sup-trans-
ducedcells,b-cateninwasmainlylocalizedtotheplasmamembrane
at sites of cell-cell contact (Figure S3A), but relocation to the cytosol
was additionally found in Cx43shRNA-transduced fibroblasts
(Figure S3A, arrows), with evidence for some nuclear localization
(Figure S3A, arrowhead). Alpha-catenin was seen localized in both
the plasma membrane and the cytosol in p.Sup and Cx43shRNA-
transducedcells(FigureS3C),andexpressionlevelsandlocationdid
not change with Cx43 knockdown (Figure S3D).
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accelerate the rate of fibroblast migration
Targeting Cx43 for knockdown accelerates the rate of wound
closure in vivo [6]. However, the underlying mechanism remains
unknown. We investigated whether the increase in cell migration
following a reduction in Cx43 expression was associated with
reduction of ZO-1 protein levels or decreased cell adhesion (ZO-1
or N-cadherin down-regulation, respectively).
We first evaluated the migration rate of fibroblasts transduced
with Cx43shRNA or p.Sup vectors, or cells treated with
Cx43asODN or control Cx43sODN. Similar to Cx43shRNA
cells, fibroblasts treated with Cx43asODN showed greatly reduced
Cx43 protein levels and GJIC compared to Cx43sODN, or
Figure 1. Dermal Cx43 is greatly upregulated in human chronic VLU. (A) Cx43 expression levels are reduced at the dermal wound margins
4 hours after leg punch biopsy of the skin of healthy volunteers. Scale bar=25 mm. Blue signal is Hoechst staining of nuclei and collagen bundle
autofluorescence. The dotted white line shows the border between the epidermis and the dermis (B) Cx43 levels increased with progressive distance
from the injury site (C). Values represent mean 6 SD (n=3; **p,0.01). (D) A representative picture of a chronic VLU in the lower leg of a patient, from
which a wound edge punch biopsy has been taken – white dotted circle. (E) Dermal Cx43 expression levels were significantly upregulated in chronic
VLU in comparison to matched non-wounded samples (n=6; *** p,0.005). (F) Graph depicting Cx43 levels in VLU vs. non-wounded skin. Values were
expressed as mean 6 SEM. Scale bar=25 mm.
doi:10.1371/journal.pone.0037374.g001
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p,0.01). We also transiently transfected fibroblasts with a bicis-
tronic pIRES-GFP empty vector (pGFP) or with a matching vector
encoding GFP and either wild-type Cx43 (Cx43-WT), or
a dominant negative Cx43 construct (Cx43-DN) that interferes
with the traffic of endogenous Cx43 protein to the plasma
membrane, thereby blocking GJIC [21].
Figure 2. Increased expression of N-cadherin and ZO-1 in the dermis of human chronic VLU (A) ZO-1 expression levels are elevated
in the dermis of chronic VLU compared to matched non-wounded controls (n=6). Scale bar=25 mm. Higher magnifications of VLU and
intact skin (boxed regions 1 and 2) stained for ZO-1 (green) and Hoechst (blue) are shown. Scale bar=10 mm. (B) N-cadherin is significantly
upregulated in chronic VLU compared to matched non-wounded samples (n=6). Scale bar=25 mm. The boxed regions 1 and 2 show high
magnifications of VLU and non-wounded skin samples stained for N-cadherin (green) and Hoechst (blue). Scale bar=10 mm. Values represent mean
6 SD. (C and D) Graphs show ZO-1 and N-cadherin expression levels in VLU vs. non-wounded skin. Values for ZO-1 and N-cadherin were expressed as
mean 6 SD; **p,0.01 and p,0.005, respectively.
doi:10.1371/journal.pone.0037374.g002
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cells was significantly faster than p.Sup or Cx43sODN control
cells, respectively (Figure 4, C and D, p,0.005; Movie S1; Figure
S2, C and D; Movie S2). Cx43 knockdown cells also displayed
much more extensive lamellipodia than control cells (Figure 4C,
Movie S1). Similarly, Cx43-DN-transfected fibroblasts migrated
faster than their untransfected neighbors or pGFP control cells,
and also extended larger than usual lamellipodia at the leading
edge (Figure S2, E and F; Movie S3). Conversely, fibroblasts
overexpressing Cx43 (Cx43-WT) migrated significantly slower
than either pGFP or Cx43-DN constructs (Figure S2, E and F;
p,0.05 and p,0.01 respectively; Movie S3). These data provide
further evidence for an inverse correlation between Cx43 protein
levels and the rate of fibroblast migration after scratch wounding.
However, there have also been reports that siRNA reduction of
Cx43 can slow cell migration in 3T3 cell scratch wound assays that
have been serum starved for 2 days [22]. We repeated these
experiments in serum starved conditions and in the presence of
normal amounts of cell culture serum. We found that in serum-
starved conditions reducing Cx43 protein levels slowed migration
whilst in more normal media conditions with serum, reducing
Cx43 significantly sped migration (Figure S2 J).
We then analyzed the velocity of migration of fibroblasts
transduced with N-cadherin or Mock shRNA constructs (N-
cadshRNA and Mock, respectively). The N-cadshRNA construct
effectively suppressed N-cadherin expression in NIH3T3 fibro-
Figure 3. Targeting Cx43 reduces N-cadherin and ZO-1 expression in fibroblasts. (A) ZO-1 or (B) N-cadherin expression levels were
examined in mouse skin wounds treated in vivo with Cx43sODN or Cx43asODN (n=6). Downregulation of ZO-1 and N-cadherin was found in the
dermis of mice after Cx43 knockdown. Graphs represent mean 6 SD; * p,0.05 and **p,0.01. (C–D) ZO-1 and Cx43 levels were analyzed by Western
blot in Cx43shRNA and p.Sup-transduced fibroblasts. Tubulin was included as loading control. Quantification shows that knockdown of Cx43 reduced
the expression of ZO-1 (***p,0.005; n=3). (E) ZO-1 (red) and Cx43 (green) expression and distribution in leading edge (LE) and internal areas (IA)
were analyzed by confocal microscopy in wounded Cx43shRNA or p.Sup-transduced cells (n=4). Cells were also counterstained with Hoechst (blue).
Scale bar=20 mm. (F) N-cadherin expression levels were significantly reduced after targeting Cx43 (**p,0.01; n=3). (G) N-cadherin (green)
redistribution from membrane (arrowheads) to cytosolic compartments (arrows) was analyzed along with F-Actin (red) in p.Sup and Cx43shRNA
fibroblasts 3 h after scratch wounding of confluent 3T3 monolayers (n=3). Scale bar=20 mm.
doi:10.1371/journal.pone.0037374.g003
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cell migration in scratch wound assays almost to the same extent as
in Cx43shRNA transduced cells (Figure 4, C and D). To reduce
ZO-1 expression in fibroblasts, cells were treated with ZO-1 sense
and antisense oligodeoxynucleotide (ZO-1sODN and ZO-
1asODN), previously described as able to effectively reduce ZO-
1 expression [24]. Contrary to Cx43 and N-cadherin, ZO-1 down-
regulation (Figure 4B) did not have any effect on the rate of
fibroblast migration or wound closure (Figure 4, C and D). These
results indicate that targeting Cx43 may additionally contribute to
cell migration by reducing N-cadherin, but not ZO-1 protein
levels in fibroblasts.
Cx43 and N-cadherin regulate cell adhesion, polarization
and proliferation in fibroblasts
Downregulation of the machinery of cell-cell adhesion is one of
the ways in which different cell types, including skin cells,
reactivate themselves to acquire a migratory phenotype [25].
Hanging drop assays have previously been used to characterize the
strength of intercellular adhesion [26,27]. We used this strategy to
compare cell-cell adhesion properties by measuring the size of cell
clusters that formed in suspended drops, and which resisted
trituration with a micropipette tip [27]. Clusters were evaluated by
morphometric image analysis and classified into three size groups
according to their area [26]. Cx43shRNA and N-cadshRNA-
transduced cells formed fewer trituration-resistant clusters (area
.2.5610
3 mm
2) and smaller clusters (area ,7.5610
2 mm
2)
characteristic of reduced cell-cell adhesion (Figure 5, A and B;
p,0.005).
The redistribution of the Golgi apparatus is an important event
in the polarization and migration of many types of cells, including
fibroblasts [28]. To examine the role of Cx43 and N-cadherin in
cell polarity during cell migration, we analyzed the localization of
the Golgi protein GM130 in fibroblasts transduced with
Cx43shRNA, N-cadshRNA, or their respective controls. Increased
GM130 polarization towards the wound was observed in
Cx43shRNA and N-cadshRNA cells compared to p.Sup and
Mock controls, 3 h after wounding (Figure 5, C and D; p,0.05).
Cell proliferation was also investigated using an IncuCyte
TM
live-cell imaging system. A clear reduction of cell growth was
Figure 4. Cx43 and N-cadherin knockdown accelerates the rate of fibroblast migration. (A and B) N-cadherin and ZO-1 expression was
evaluated by Western blot in Mock or N-cadshRNA-transduced cells, and in ZO-1asODN or sense-treated (ZO-1sODN) cells, respectively. Values
represent mean 6 SD (n=3, ***p,0.005; n=3, *p,0.05). (C) Cx43shRNA and p.Sup cells, Mock and N-cadshRNA cells, or fibroblasts treated with ZO-
1sODN and ZO-1asODN were allowed to migrate into a wound for 3 h. Pictures of cells at the beginning of the migration recording (0 h) and at the
end (3 h) are shown. (D) The graph shows the velocity of migration for all the aforementioned conditions. Values represent mean 6 SEM
(***p,0.005).
doi:10.1371/journal.pone.0037374.g004
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compared to p.Sup and Mock control cells (Figure 5, E and F),
indicating a direct correlation between Cx43 and N-cadherin
expression, and cell proliferation in fibroblasts.
AltogetherthesedataconfirmtheimportantcontributionofCx43
and N-cadherin to the regulation of cell polarization, adhesion and
proliferation processes in fibroblasts during wound repair.
Targeting Cx43 induces cytoskeletal changes in leading-
edge fibroblasts
Using scratch wound assays we observed that polarized Cx43
knockdown cells in the wound edge extended larger than usual
lamellipodial protrusions (Movies S1 and S2). Directional cell
locomotion requires complex interactions between actin filaments
(F-actin) and microtubules, and we analyzed the distribution of F-
Figure 5. Cx43 and N-cadherin contribute to cell polarization, adhesion, and proliferation in fibroblasts. (A–B) Cell–cell adhesion upon
suspension in hanging drops was assessed for Cx43shRNA and p.Sup, and for Mock and N-cadshRNA cells. The areas of cell clusters in six random
fields taken from six different hanging drops were determined for each condition. Graphs represent the average number of clusters falling into each
of three size ranges for each condition. Scale bar=300 mm. (C–D) Cx43shRNA and p.Sup, and Mock and N-cadshRNA cells were wounded, allowed to
migrate for 3 h, and then fixed and immunostained with anti-GM130 (red) and Hoechst (blue). Scale bar=25 mm. The percentage of cells with Golgi
located in the 120u arc facing the wound were scored as positive. Between 66–106 cells were evaluated in n=3 independent experiments. Data
represent the mean 6 SEM (*P,0.05). Growth curves showing cell proliferation of fibroblasts transduced with (E) p.Sup and Cx43shRNA, and (F) Mock
and N-cadshRNA constructs are shown. Data represent mean 6 SD of three independent experiments, performed in duplicate.
doi:10.1371/journal.pone.0037374.g005
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monolayers after targeting Cx43 expression in fibroblasts. Front-
row control Cx43sODN, pGFP-transfected and p.Sup fibroblasts
displayed the F-actin belt typical of polarized migratory cells
(Figures 6A and 7A arrowhead; Figure S4A), which is regulated by
adherens junctions [29]. In contrast, Cx43asODN, Cx43-DN and
Cx43shRNA wound-edge cells developed rich lamelipodial
protrusions oriented in the direction of movement, and lacked
the F-actin belt found in control cells (Figures 6A and 7B
arrowhead; Figure S4A). Under control conditions, tyrosinated
and acetylated microtubules (TyrTub and AcetTub, respectively)
were arranged very much as previously described in wounded
fibroblast monolayer experiments [30], fanning out from the
perinuclear region towards the wound margin. In Cx43asODN,
Cx43shRNA, and Cx43-DN cells, which tended to be more
extended, tyrosinated microtubules were predominantly oriented
perpendicularly to the wound edge (Figures 6A and 7B arrowhead;
Figure S4A). Cells over-expressing Cx43 (Cx43-WT) showed
microtubules and lamellipodia that were less extensive than pGFP-
transfected control cells (Figure 7C).
Lamellipodial dynamics were analyzed in more detail by
transfecting fibroblasts with a red fluorescent protein (RFP)-actin
construct. Sixteen hours after RFP-actin transfection a confluent
monolayer was scratch-wounded and imaged for 1.5 hours by
confocal microscopy. The p.Sup cells showed active, actin-rich
lamellipodia and filopodia (Movie S4) and actin remodeling,
characterized by dynamic formation and collapse of filopodia and
actin ruffles in front-row cells. Cx43shRNA transduced fibroblasts
displayed considerably more extensive actin-rich membrane pro-
trusions at the front of the leading-edge cells (Movie 4). We
quantified the extent of the cell protrusion and found that
Cx43asODN, Cx43-DN and Cx43shRNA cells displayed almost
twicetheaverageprotrusionlengthexhibitedbyCx43sODN,pGFP
and p.Sup control cells (Figures 6B and 7D; Figure S4B).
Following demonstration that Cx43 knockdown reduced N-
cadherin expression, which also contributes to accelerate cell
migration in fibroblasts (Figure 4D), we analyzed the distribution
of polymerized actin in N-cadshRNA and Mock transduced cells
3 h after wound-scratch experiments. Similar to Cx43 knockdown
fibroblasts, wound edge N-cadherin-targeted cells extended rich
lamellipodial protrusions oriented towards the direction of cell
migration (Figure S5A), and quantification showed more extensive
lamellipodia protrusions compared to Mock control cells (Figure
S5B).
Targeting Cx43 and N-cadherin increases Rac1 and Rho-A
GTPase activities in fibroblasts
Rho GTPases are key regulators of actin and microtubule
dynamics and have an essential role in controlling different actin-
based structures critical for cell motility and chemotactic responses
[31]. We examined the effect of Cx43 and N-cadherin knockdown
on Rho family GTPase activation in fibroblasts, using pull-down
assays with specific GST fusion protein-binding domains for
activated Rac1, Cdc42 and RhoA (GTP-bound forms). Quanti-
tative analysis showed enhanced Rac1 and RhoA activity in
Cx43shRNA and N-cadshRNA cells compared to p.Sup and
Mock controls, respectively (Figure 8, A and B). In contrast, no
differences in Cdc42 GTPase activity were detected.
To examine the activation of Rho GTPases in more detail,
biosensors for Rac1, RhoA and Cdc42 [32,33] were transfected
into either p.Sup or Cx43shRNA-transduced cells and FRET was
used to examine the activity of these GTPases in leading edge
fibroblasts 3 hours after scratch-induced migration. Targeting
Cx43 with Cx43shRNA induced a two-fold increase in Rac1 and
RhoA activity over the p.Sup control (Figure 8, C and E; p,0.05),
but had no effect on the activity of Cdc42 (Figure 8E). These
findings support a direct role for Cx43 in the regulation of
cytoskeletal dynamics in fibroblasts during cell migration.
Discussion
Chronic wounds are a significant and growing global problem
and place a great burden on both patients and healthcare system
resources. While chronic wounds can occur anywhere on the
body, most fall within the categories of VLUs, diabetic foot ulcers
and pressure ulcers, which fail to progress through an organized,
orderly and timely sequence of wound repair. Acceleration or even
stimulation of wound closure is important for these chronic
wounds, which are often infected and inflamed, making them
painful and debilitating for the growing numbers of elderly and
diabetic patients, and putting them at risk of lower limb
amputation. Here we show that Cx43 is markedly upregulated
in the dermis of human chronic VLU, similar to what was found in
the wound edge epidermis of STZ diabetic rats, a feature that
underlies impaired migration and healing [15]. We do not have
ethical approval to biopsy and treat human VLU with Cx43
antisense and then resample these hard to heal wounds with
additional biopsies. We therefore utilised a fibroblast cell line
where we could reliably manipulate Cx43 protein expression and
explore the effects on the dynamics of cell migration in a scratch
wound healing assay. Whilst this is not as authoratative as in vivo
human studies, they are useful for exploring the effect of Cx43
modulation on fibroblast behaviour. In these cell-culture experi-
ments, fibroblast migration was impaired when Cx43 protein
levels and GJIC were elevated after transfection with a Cx43-WT
construct. These findings support a conclusion that the impaired
healing observed in human chronic VLU wounds might be
a consequence of the reduced rate of fibroblast migration caused
by elevated levels of Cx43 protein.
However, elevated levels of Cx43 may not be the only factor
that compromises healing in VLU. Cx43 reportedly forms
a multiprotein complex or ‘nexus’ with ZO-1, a- and b-catenin,
and N-cadherin [17,18,34], proteins that are likely to influence
both cell adhesion and migration in wound healing. In fact, when
compared to intact skin, we found that both ZO-1 and N-cadherin
were significantly upregulated in the dermis of human chronic
VLU, along with Cx43 upregulation. Clinically relevant is the
observation that silencing Cx43 accelerated the velocity of
fibroblast migration, supporting the idea that this process can be
therapeutically controlled. Using in vitro models it was recently
reported that connexin mimetic peptides also improve the
migration rates of dermal fibroblasts [35], as well as keratinocyte
and fibroblast migration in organotypic models and 2D cultures
[36], which further reinforce our observations. These studies
reported that levels of Cx43 protein were not changed by the
peptide but phosphorylation of Cx43 was increased and cell
adhesion decreased [35,36]. We found that directly targeting Cx43
protein production additionally reduced N-cadherin and ZO-1
protein levels in vivo, with redistribution of both proteins from the
plasma membrane to the cytosol. In the case of ZO-1, the protein
was noticeably lost from the leading edge lamellipodia, which is
normally a feature of fibroblast migration in scratch assay wound
healing [37] and this may bring about changes in the distribution
of the cytoskeletal components to which it binds.
The cytoplasmic tail of Cx43 is able to interact with the PDZ2
domain on ZO-1 but this interaction can be competed out by the
addition of a mimetic peptide (ACT-1) to the last 9 amino acids of
the Cx43 tail [38]. This peptide has been reported to stabilize
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[38]. Applied to acute skin lesions this peptide is reported to
accelerate wound healing whilst reducing scar formation, actions
that are similar to those of the Cx43 antisense [39,40,41]. The
mechanism behind the reported action of the peptide on wound
healing is not at all clear at present. Interestingly, while
knockdown of Cx43 and N-cadherin accelerated cell migration
in a scratch wound-healing assay, targeting of ZO-1 failed to speed
up fibroblast migration, indicating that ZO-1 down-regulation
does not account for the faster migration that occurs when Cx43 is
downregulated. It would be interesting in future studies to see if
the ACT-1 peptide is able to accelerate fibroblast migration.
The literature regarding GJ communication and cell migration
contains conflicting reports. Elevated connexin expression has
been associated with reduced migration [42,43], while other
authors have reported the opposite effect [44,45]. Using a different
approach, in vitro studies performed on NIH 3T3 cells showed that
the dynamic spreading movement, over an hour, of individual
isolated and non-wounded cells appeared to be reduced when
Cx43 was downregulated with siRNAs [17]. This discrepancy may
reflect the different cell states (wounded vs. non-wounded) and
different models used (cell migration into a scratch-wound vs. the
spreading of non-wounded cells in sparse cultures). More recently
the same group reported that Cx43 KO mouse embryonic
fibroblasts migrated more slowly in scratch wound assays than
those with Cx43 [22]. The reasons for these divergent observations
are not clear but may be related to their serum starving of the cells
for 48 hours prior to performing the scratch wound assay. We
Figure 6. Targeting Cx43 induces cytoskeletal changes in leading-edge fibroblasts. (A) Representative images showing the distribution of
F-actin (red), and tyrosinated (green) and acetylated (blue) tubulin (TyrTub and AcetTub, respectively) in leading edge Cx43sODN and C43asODN
fibroblasts, 3 h after wounding. Cells were also counterstained with the nuclear marker Hoechst. Scale bar=20 mm. (B) The graph shows the length of
the protrusions of wound edge cells. Data represent the distance (mean 6 SEM) from the nucleus to the leading edge in n=3 experiments
(***P,0.005).
doi:10.1371/journal.pone.0037374.g006
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3T3 cells transduced with Cx43shRNA to reduce Cx43 expres-
sion. One batch was serum starved for 2 days, whilst the other was
not. Cultures were then scratch wounded and imaged for 4 hours.
We found that serum starved cells with reduced Cx43 migrated
more slowly whereas reducing Cx43 in the absence of serum
starvation speeded migration. As serum starvation would not be
expected to match the conditions found in an acute wound in vivo,
Figure 7. Modulation of Cx43 levels influence wound-edge cytoskeletal architecture in fibroblasts. Representative images of leading-
edge cells transfected (arrowhead) with (A) a control pGFP construct (B) Cx43-DN, or (C) Cx43-WT, stained for TyrTub, F-actin and Hoechst. Scale
bar=20 mm. (D) Graph depicting the length of lamelipodial protrusions of fibroblasts transfected with the different constructs is shown (**p,0.01;
***P,0.005; n=3).
doi:10.1371/journal.pone.0037374.g007
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speeds migration of fibroblasts and keratinocytes, we can only
assume that it is the abnormal conditions of serum starvation that
is triggering the anomalous response.
Cadherin-mediated cell–cell adhesion is reported to coordinate
junction development with cell movement and cell polarization,
and to maintain junction integrity by forming links with actin
filaments [46]. Disruption of N-cadherin has been reported to
increase the rate of Schwann cell migration on astrocytes by
enhancing both the number of migrating cells, and the maximum
migration distance [47]. Here we demonstrated that targeting
Cx43, which consistently reduced N-cadherin expression, signif-
icantly diminished cell-cell adhesion, while increasing cell polar-
ization in fibroblasts. This was further demonstrated by targeting
N-cadherin, which provided similar results. It is also possible that
decreased cell-cell adhesion is contributed to by a direct loss of
Cx43–Cx43 connexon docking in Cx43-targeted fibroblasts. This
was previously confirmed in cadherin null human squamous
Figure 8. Cx43 and N-cadherin knockdown increases Rac1 and RhoA GTPase activity in fibroblasts. (A) Rho GTPase (GTP) activities in
wounded fibroblasts were measured by pull-down assays using the PBD domain of PAK (Rac1 and Cdc42), or the RBD domain of Rhotekin (RhoA),
followed by immunoblotting with the respective antibodies. Additionally, Rac1, Cdc42 and RhoA from total lysates were used as loading controls. (B)
Graphs show active Rac1 and RhoA GTPase activity (GTP levels/total levels; mean 6 SEM, *P,0.05); n=3 independent experiments. Representative
images of leading edge Cx43shRNA and p.Sup transduced cells showing (C) Rac1, and (D) RhoA GTPase activities, 3 h after wounding of confluent
monolayers. Scale bar=10 mm. Arrows indicate the direction of migration. (E) FRET efficiency analysis show a two-fold increase in Rac1 and RhoA
activities in Cx43shRNA vs. p.Sup-transduced cells, while no differences were observed for Cdc42. Data is representative of n=3 experiments per
condition; *p,0.05.
doi:10.1371/journal.pone.0037374.g008
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of Cx43 increased cell adhesitivity [49,50]. In the same way,
interfering with Cx43 in individual cells of the 8–16 cell mouse
embryo has previously been shown to reduce adhesion and
produce decompaction of the targeted cell [51], whereas ZO-1 has
recently been described to be essential for the compaction step
[52]. Based on the findings described here we conclude that Cx43
down-regulation may prevent maturation of stable cell–cell
adhesions by reducing N-cadherin expression and/or docking of
connexons themselves.
We found that sustained reduction of the expression of either
Cx43 or N-cadherin in 3T3 cells, by transduction with shRNA
resulted in reduced cell proliferation. At first this observation does
not seem to fit with previous reports from our group and others
relating to Cx43 and cell proliferation. We have found that
applying Cx43 antisense to an excisional wound on a mouse
results in increased proliferation of fibroblasts and nascent
keratinocytes but this was 1, 2 & 7 days after the treatment by
which time the antisense was no longer preventing Cx43 protein
production [7]. Pollock et al., 2011 [36] reported that the mimetic
peptide GAP27 could in some cases enhance cell proliferation at
the leading edge of a scratch wound assay of keratinocytes or
fibroblasts. This effect was brought about without apparently
reducing Cx43 protein levels and so the differences observed when
Cx43 protein is significantly reduced may reflect the direct effect of
the presence of the Cx43 protein on cell proliferation rather than
the effect of Cx43 based gap junctional communication.
Trafficking of Cx43 hemichannels to cell–cell junctions takes
place through a pathway that is dependent on microtubules [18],
and it is well known that the cytoplasmic tail of Cx43 is able to
interact with various components of the cytoskeleton, including
microtubules and actin [18,53,54,55,56]. Here we show that front-
row migrating fibroblasts lacking N-cadherin or Cx43 adopt an
elongated phenotype with lamellipodia extended into the wound
bed in the direction of migration. In contrast, actin organization in
control-wounded fibroblasts was characterized by the F-actin belt
typical of polarized migratory cells, known to be regulated by
adherens junctions [29]. We also identified enhanced Rac1 and
RhoAactivitiesinCx43andN-cadherin-targetedfibroblasts,yetthe
molecular mechanism by which these proteins regulate Rho
GTPase activation remains to be elucidated. However, these
findings correlate with a reported role for RhoA in regulating
fibroblast protrusion as an initiator of actin polymerization at the
onset of the protrusion-retraction cycle [57]. Rac1, on the other
hand, can influence the reinforcement and stabilization of newly
expanded protrusions [57], which may help to explain the faster
migration and more extensive lamellipodia observed in Cx43-
targeted fibroblasts. The organization of the microtubule cytoskel-
eton was also investigated and found to be altered after reducing
Cx43 levels, indicating that Cx43 not only interacts directly with
microtubules, but may also affect microtubule dynamics during
fibroblast migration. A finding that is in agreement with recent
observations by Francis et al 2011showing altered microtubule
dynamics in Cx43 KO mouse embryonic fibroblasts [22].
Overall, this study provides insight into why chronic VLUs that
we have found to overexpress Cx43 in the dermis are slow to heal,
and the cellular mechanisms as to how reducing Cx43 and N-
cadherin expression accelerates fibroblast migration, pointing to
a potential therapeutic solution to this debilitating problem. Our
findings support the concept that the role of Cx43 is not simply to
form GJ channels, but also to stabilize a nexus or multiprotein
complex comprising N-cadherin, amongst others, that is required
for cell-cell adhesion and adhesion-dependent actin dynamics, and
must be broken down to facilitate efficient fibroblast migration. A
large Phase 2 clinical trial is now underway using the Cx43asODN
to reduce Cx43 expression in subjects with VLUs after an initial
clinical trial showed significant improvement in complete healing.
Materials and Methods
Human chronic VLU and matched intact skin samples
Collection of wound edge punch biopsies from chronic venous
ulcer leg wounds and normal arm biopsies was approved by the
Western Institutional Review Board, Olympia, Washington State,
USA. Punch biopsies from the thigh of healthy volunteers were
under approval by the Northern X Regional Ethics Committee,
Auckland, New Zealand. All biopsies were taken after written
informed consent was obtained and the clinical research executed
in accordance with the principles of the Declaration of Helsinki.
Briefly for the VLUs a single 4 mm punch biopsy was taken from
the wound edge under local anaesthesia in patients with clinically
confirmed venous ulceration. A second 4 mm punch biopsy was
taken from normal skin on the forearm in the same subjects. In all,
biopsies from 6 subjects with clinically confirmed VLU (3 male
and 3 female; range 38–79 years) were taken: median ulcer
duration 6 months (range 1.5–36 months), and median size
10 cm
2 (range 2–113 cm
2). The VLU biopsies were initially fixed
overnight with 4% paraformaldehyde (PFA), then transferred to
25% sucrose, and stored at 4uC until processing. For immunohis-
tochemistry, tissue biopsies were embedded in OCT (BDH, UK).
Samples were cryo-sectioned (10 mm) for immunohistochemistry
analysis. For the normal (acute) wound biopsies an initial 6 mm
punch biopsy was performed under local anesthetic on the
anterolateral thigh of 3 healthy male volunteers (range 20–36
years) and then 4 hours later the punched wound site was excised
with a larger 10 mm punch, and the resulting wound sutured
closed. The 2 mm wide donut shaped biopsy was immediately
imbedded in OCT snap frozen in liquid nitrogen and then stored
at 280uC until being cryosectioned before analysis.
Mouse and rat cutaneous wound-healing model and
ODNs application
Male, 8-week-old ICR mice or Sprague-Dawley rats from UCL’s
Biological Services Unit were maintained according to UK Home
Office animal regulations. Excisional lesions were performed as
previously described [7]. Single topical applications of 10 mM
unmodifiedCx43asODNandcontrolCx43sODN(Sigma-Genosys)
were delivered to each of two independent wounds in 30% Pluronic
F-127 gel (Sigma). Two days after wounding, animals were
humanely sacrificed and the wound tissue was harvested.
Cell cultures and ODNs treatment
3T3 fibroblasts were grown in DMEM-GlutaMAX
TM-1 (Gibco,
Invitrogen) supplemented with 10% FBS (Gibco, Invitrogen) in
5% CO2 at 37uC. For ODN treatments fibroblasts were washed
with PBS to eliminate any traces of serum, and were incubated in
serum free media for 2 hours with 20 mM Cx43asODN or
Cx43sODN [6] (Sigma-Genosys); or with 10 mM ZO-1asODN or
ZO-1sODNs [24] (Sigma-Genosys). Following this incubation, the
medium with the ODNs was removed and replaced by 10% FBS
in DMEM.
Transfection; retroviral and lentiviral constructs and
transduction
A retroviral pSuper vector containing the Cx43-specific shRNA
target sequence GGTGTGGCTGTCAGTGCTC [20], kindly
donated by W.H. Moolenaar and here designated Cx43shRNA,
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fibroblasts. A pSuppressor (p.Sup) retroviral vector (Imgenex Co)
was used as control. The packaging cell line GP2–293 (Clontech)
was transfected with the p.Sup and Cx43shRNA constructs as
previously described [58]. Mock and N-cad shRNA constructs
[23], kindly provided by S Arai and T Suda, were transfected into
HEK 293T cells according to [59]. 3T3 fibroblasts were
transduced with retrovirus or lentivirus for 2 days, and
Cx43shRNA and N-cadshRNA and Mock-transduced cells were
selected on the basis of resistance to 2 mg/ml puromycin or
500 mg/ml of geneticin (for p.Sup).
Fugene HD (Roche) was used to transfect 70% confluent
fibroblasts with 1 mg/ml pGFP, Cx43-DN or Cx43-WT constructs
([21]) according to manufacturer’s recommendation. Media was
changed the following morning and 24 h later cells were used on
different set of experiments.
Immunohistochemistry of murine and human skin
samples
Immunostaining was carried out on 6-mm cryostat sections of
wounded rat and mouse skin, or 10-mm human chronic VLU or
matched non-wounded skin, fixed in acetone at 4uC for 5 minutes.
Primary antibodies (Abs) for Cx43 (diluted 1:2000; Sigma, 6219),
N-cadherin (diluted 1:100; Abcam, ab18203) and ZO-1 (diluted
1:100; Zymed Laboratories, 61–7300) were incubated for 1 hour
at room temperature. Sections were washed with PBS and then
incubated with the respective secondary Abs: swine anti-rabbit
FITC-conjugated (DAKO) and goat anti-mouse Cy3-conjugated
(Pierce). Secondary Abs incubation in the absence of primary Abs
was used as negative control. Sections were then counterstained
for 10 minutes with 5 mg/ml of the nuclear dye Hoechst 33342
(Sigma) and single optical sections were acquired on a Leica SP2
confocal microscope (Leica Microsystems, UK). All parameters
during image acquisition were kept constant throughout each
experiment to allow direct comparison of all of the 8 bit digital
images. Immunostaining levels were quantified per unit area using
a well-established pixel-counting method [15] using ImageJ
software (NIH). Images were converted to binary images using
an identical threshold. Objects greater than 2 pixels were counted
in order to generate a readout of the number of positive pixels per
unit area for comparison between conditions.
Immunostaining
Confluent fibroblast monolayers were wounded and fixed 3 h
later with 4% PFA for 10 minutes and permeabilized with 0.1%
Triton X-100. Primary Abs for Cx43 (diluted 1:2000; Sigma), ZO-
1 (diluted 1:100; Zymed Laboratories), N-cadherin (diluted 1:100;
Abcam), b-catenin (diluted 1:200; ab6302 Abcam), a-catenin
(diluted 1:200; C2081 Sigma), tyrosinated tubulin (diluted 1:400;
YL1/2; Ab6160 Abcam) and acetylated tubulin (diluted 1:200;
T7451 Sigma) were used according to the manufacturer’s
recommendations. Incubation with the appropriate secondary
Abs (Alexa 488 or 633; Molecular Probes) was followed by
10 minutes application of 5 mg/ml of the nuclear dye Hoechst
33342 (Sigma). Secondary Ab incubation in the absence of
primary Ab was used as negative control. TRITC-phalloidin
(Sigma) was included in some experiments for visualization of F-
actin. Cells were imaged using a 636, 1.25 NA objective on a Leica
SP2 confocal microscope (Leica Microsystems, UK). At least three
images, from 3–5 independent experiments were acquired. All
acquisition parameters were kept constant throughout each
experiment and staining was quantified based on pixel counts [15].
Golgi reorientation measurements
Measurement of Golgi reorientation was performed as de-
scribed previously [60]. Confluent fibroblasts were scratched and
incubated for 3 h. After this time, cells were fixed with 4% PFA
and stained with anti-GM130 (BD Biosciences) and Hoechst
33342 nuclear stain (Sigma). One hundred cells in ten randomly
selected fields were evaluated for Golgi orientation.
Cell proliferation
3T3 fibroblasts (1610
4 cells) transduced with pSup,
Cx43shRNA, Mock and N-cadshRNA constructs were plated
into 96-well plates and cell growth was monitored in real-time
using the IncuCyte
TM live-cell imaging system (Essen Instruments,
Ann Arbor, MI). Experiments were performed at least three times
in duplicate and data was expressed as percentage of confluence.
Measurement of protrusion length
Confluent fibroblasts transduced with Cx43shRNA, p.Sup, N-
cadshRNA and Mock constructs, or transfected with pGFP, Cx43-
DN or Cx43-WT were wounded and fixed with 4% PFA 3 h later.
The cells were then stained with Hoechst 33342 nuclear stain
(Sigma). To quantify the protrusions’ length, the distance from the
nuclei to the leading edge of wound edge cells was measured. In
each of three independent experiments, 3–5 transfected cells, or 30
transduced cells in randomly selected fields were analyzed to
calculate the average length of these protrusions.
Western blot
Cell pellets from harvested fibroblasts (Cx43shRNA- or p.Sup-
transduced) were suspended at 4uC in ice-cold RIPA buffer plus
protease inhibitors. Equal amounts of protein were resuspended
in Laemmli 46 sample buffer, separated by 10% SDS-PAGE
and visualized with primary Abs to Cx43 (diluted 1:2000; Sigma),
ZO-1 (diluted 1:500; Zymed Laboratories), a-catenin (diluted
1:200; Sigma), b-catenin b-catenin (diluted 1:1000; Abcam) or N-
cadherin (diluted 1:500; Abcam). Abs against a-tubulin or actin
(both from Sigma) were used as loading controls. Secondary
antibodies were HRP-conjugated, and protein levels were
visualized using an enhanced chemiluminescence (ECL) system
(Amersham). The ratio protein/tubulin or/actin was determined
by scanning and quantifying the bands, using ImageJ software
(NIH).
Dye-transfer assay
Dye-injection was carried out according to the method de-
scribed previously [61]. Cells were impaled under visual control
and filled with dye by iontophoresis. Communication was assessed
1 minute after cessation of iontophoresis. At least 10 injections
were performed for each set of experimental conditions. The
coupling was tested in cells: a) treated with Cx43sODN,
Cx43asODN, or control untreated cells; b) transiently transfected
with Cx43-DN, Cx43-WT or pGFP; and c) Cx43shRNA or
p.Sup-transduced cells. Images of microinjected cells were
acquired with a 4060.8 NA objective on a Leica DMLFS
microscope (Leica Microsystems, UK) using Volocity acquisition
software (Improvision/Perkin Elmer).
Cell migration assay
Confluent cultures of Cx43sODN, Cx43asODN, ZO-1asODN
and ZO-1sODN-treated fibroblasts; or Cx43shRNA, p.Sup, N-
cadshRNA and Mock-transduced cells; as well as Cx43-WT,
Cx43-DN and pGFP-transfected fibroblasts were subjected to
a mechanical scratch-wound. In some experiments, Cx43shRNA
Targeting Cx43/N-Cad to Promote Healing in VLU
PLoS ONE | www.plosone.org 13 May 2012 | Volume 7 | Issue 5 | e37374and p.Sup fibroblasts were serum starved (SS) or incubated in the
presence of serum (FBS) for 48 h as described [22]. After this
period of time, cells were wounded and incubated in DMEM
supplemented with serum. Time-lapse images were taken soon
after wounding at intervals of 5 minutes for 3–4 hours, and were
acquired on an inverted Zeiss LSM AxioPlan 400 fluorescence
microscope (Zeiss, UK), equipped with a Orca CCD camera
(Hamamatsu, UK), using a 4061.2NA objective with an
incubation chamber at 37u and 5% CO2. Time-lapse images
were captured using OpenLab image acquisition software
(Improvision/Perkin Elmer, UK). The migration velocities of
individual fibroblasts were quantified using Volocity4 analysis
software (Improvision/Perkin Elmer) by measuring the distance
between the initial and final positions of leading edge cells
3 hours after wounding. For each experimental condition,
velocities were presented as mean 6 SD (mm/sec).
Rho GTPase activition assays
Fresh lysates were used for Rac1/Cdc42 and RhoA-pulldown
assays, using the Rac/Cdc42-binding domain (p21-binding
domain, PBD) of PAK, as previously described [62], or GST-
Rhotekin (kind gift of P Rodriguez-Viciana) to detect relative
amounts of RhoA-GTP. Bound protein (GTP-bound Rac1,
Cdc42 or RhoA) levels were detected by western blot. Total
Rac1, Cdc42 and RhoA from total cell lysates were also analyzed
as loading controls.
Fo ¨rster resonance energy transfer (FRET)
Plasmids encoding FRET probes [Raichu-Rac1, Raichu-
Cdc42 [32] and RhoA biosensor [33] were transfected into
Cx43shRNA or p.Sup-transduced fibroblasts using Fugene HD
(Roche). The FRET efficiency of the cells expressing the EYFP-
ECFP fusion construct was measured using confocal fluorescence
microscopy and acceptor photobleaching. Leading-edge trans-
fected cells were imaged using an Olympus FluoView 1000 laser
scanning confocal microscope and a 6061.4NA oil objective
(Olympus Microscopes, UK). The CFP and YFP channels were
excited using the 440 nm and 515 nm lasers, respectively. The
two emission channels were 460–510 nm for CFP and 520–
620 nm for YFP. The gain for each channel was set to
approximately 75% of dynamic range (12-bit, 4096 grey levels)
and offsets set such that backgrounds were zero. Pre- and post-
bleach CFP and YFP images were acquired and the FRET mode
was used to collect images for each channel after acceptor
bleaching with 10–12 scans of the 515 nm argon laser line at
maximum power (to bleach YFP). The Olympus FluoView 1000
software was used to analyze donor and acceptor intensity values
before (pre) and after (post) bleaching and values were then
extracted from pixels falling inside the cell of interest, as well as
an equal-sized bleached region outside the cell, and the mean
ratio was determined for each region. The FRET efficiency ratio
over the whole cell was calculated using the following formula:
FRET efficiency=[ID (post)2ID (pre)]/ID (post), where IDpre and
IDpost refer to the intensity of the donor (CFP) before (pre) and
after (post) photobleaching of the acceptor (YFP).
Hanging drop assay
Approximately 20,000 single cells were suspended in 35 ml
drops of 10% FBS in DMEM from the lids of 24-well dishes for
4 hours. Water was placed at the bottom of each well to
maintain humidity. The drops were pipetted five times up and
down with 200 ml yellow tips, fixed with 4% paraformaldehyde,
and aliquots were spread on coverslips. Images of six random
fields from six individual samples for each condition studied
(p.Sup and Cx43shRNA-transduced cells) were taken with
a4 60.1 NA objective on an inverted Axiovert Zeiss LSM
microscope. An area of approximately 2.5610
2–7.5610
2 mm
2
corresponds to a cluster of 1–3 cells and 2.5610
3 mm
2
corresponds to about 10 cells. The area of each cell cluster
was determined using a custom-written plug-in for ImageJ
software (NIH). The area occupied by single cells was measured
in parallel to estimate the amount of cells per unit area.
Statistical analysis
Statistical differences were determined using Wilcoxon
Matched-Pairs Signed-Ranks Test for paired data, or one-way
analysis of variance (ANOVA) for data sets of multiple compar-
isons. A two-tailed Chi-squared test was used for the analysis of cell
cluster sizes in the hanging drop assay of adhesion. All data are
presented as the mean 6 SD except where stated. Criterion levels
for the individual tests are given in the Results.
Supporting Information
Figure S1 Cx43 is downregulated in fibroblasts after
wounding. (A) The expression and distribution of Cx43 in
mouse’s skin dermis was examined by immunohistochemistry 2 d
after excisional wounding. Wound-edge Cx43 was reduced in
dermal fibroblasts after such wounds. Arrowheads show how Cx43
becomes more prevalent with increasing distance from the wound
edge. Scale bar=25 mm. Cx43 levels were quantified along the
wound site and were significantly lower at the wound edge;
p,0.005. Values are expressed as mean 6 SD. (B) ZO-1 (green)
and Cx43 (red) were examined in mouse skin wounds treated in
vivo with Cx43sODN or Cx43asODN (n=6). Cells were also
counterstained with Hoechst (blue). A clear downregulation of
ZO-1 was found in the dermis of mice treated with the
Cx43asODN. Scale bar=100 mm. (B) Excisional wounds treated
with Cx43asODN or control Cx43sODN were used to evaluate
the distribution of N-cadherin (green) by immunohistochemistry.
Scale bar=100 mm.
(DOCX)
Figure S2 Knockdown of Cx43 induces cytoskeletal
changes. (A) Cx43 expression levels and (B) cell-cell communi-
cation were evaluated in Cx43asODN or LiCl-treated 3T3
fibroblasts, and in untreated or sense-treated (Cx43-sODN)
controls. Values are expressed as mean 6 SD (*p,0.05;
**p,0.01 and ***p,0.005; n=4). (C) Confluent monolayers
treated with Cx43sODN, Cx43asODN or LiCl were wounded
and allowed to migrate for 3 hours. Pictures of cells at the
beginning of the migration recording (0 hours) and at the end
(3 hours) are shown. Scale bar=25 mm. (D) The graph shows the
velocity of migration, which was inversely correlated with both dye
coupling and Cx43 expression. Values represent mean 6 SEM
(*p,0.01; ***p,0.05; n=6). (E) Cells transfected with Cx43-DN,
Cx43-WT or pGFP constructs (n=3), as well as Cx43shRNA or
p.Sup-infected cells (n=6), were allowed to migrate into a wound
for 3 hours. Images were taken at the beginning of the migration
recording (0 hours; arrows pointing to Cx43-DN, Cx43-WT, or
pGFP-transfected cells) and 3 hours later (arrowheads pointing to
Cx43-DN, Cx43-WT or pGFP). Cx43shRNA and Cx43-DN cells
accelerated migration, while Cx43-WT slowed it. Scale
bar=25 mm. (F) The graph shows the velocity of migration for
each treatment and confirms that either silencing of Cx43 or
transfection with Cx43-DN induce a significant increase in the rate
of migration relative to the other conditions analyzed. Data are
expressed as mean 6 SD (*p,0.05; **p,0.01; n=4). (G) Cx43
levels and dye coupling after LY microinjection were assessed in
Targeting Cx43/N-Cad to Promote Healing in VLU
PLoS ONE | www.plosone.org 14 May 2012 | Volume 7 | Issue 5 | e37374Cx43shRNA or p.Sup-infected 3T3 fibroblasts. Cx43shRNA was
effective in downregulating Cx43 and eliminating communication
with neighbouring cells. Values represent mean 6 SEM for Cx43
levels, and mean 6 SD for cell coupling (***p,0.005; n=4). (J)
Cx43shRNA and p.Sup cells were grown in the presence (FBS) or
absence (SS) of serum and allowed to migrate into a wound for
4 h. The graph shows the velocity of migration; values represent
mean 6 SEM of n=3 independent experiments (***p,0.005).
(DOCX)
Figure S3 Analysis of a- and b-catenin expression and
distribution after targeting Cx43. (A and C) Protein
distribution of a- and b-catenin was analyzed in p.Sup and
Cx43shRNA-infected fibroblasts 3 h after wound scratch of
confluent 3T3 monolayers. Arrows in (A) indicate cytoplasmic
relocation of b-catenin from the plasma membrane to the cytosol
in Cx43shRNA-infected cells. The single arrowhead indicates a site
of putative nuclear localization of b-catenin in Cx43shRNA-
infected fibroblasts. Scale bar=25 mm. (B and D) The expression
levels of these proteins were also evaluated by Western blot and
values were normalized with respect to actin or tubulin (Tub).
(DOCX)
Figure S4 Knockdown of Cx43 induces cytoskeletal
changes. The distribution of TyrTub, AcetTub, and F-actin
was studied 3 h after wounding confluent monolayers of
Cx43shRNA and p.Sup transduced fibroblasts. Scale
bar=25 mm. The graph shows the length of the protrusions of
wound edge cells and data represent the distance from the nucleus
to the leading edge (mean 6 SEM; n=3 experiments;
***P,0.005).
(DOCX)
Figure S5 Knockdown of N-cadherin increases lamelli-
podial protrusions. (A) The distribution of F-actin was studied
3 h after wounding confluent monolayers of Cx43shRNA and
p.Sup transduced fibroblasts. Targeting N-cadherin induces
cytoskeletal changes in wound edge cells. Scale bar=25 mm. (B)
The graph shows the length of the protrusions of control (Mock)
and NcadshRNA wound edge cells. Data represent the distance
from the nucleus to the leading edge (mean 6 SEM; n=3
experiments; ***P,0.005).
(DOCX)
Movie S1 Cx43 expression influences the velocity of
migration scratch wounded fibroblasts. Time-lapse record-
ings of cells treated with Cx43sODN, Cx43asODN or LiCl were
performed at intervals of 5 min for a period of 3 h. Cx43asODN-
treated cells migrated almost twice as fast as Cx43sODN treated
cells and displayed an extensive lamellipodial protrusion at the
leading edge. Incubation with LiCl significantly reduced the rate
of migration.
(MOV)
Movie S2 Knockdown of Cx43 accelerates the rate of
fibroblasts migration. Fibroblasts stably transfected with
Cx43shRNA or p.Sup were monitored for 3 h and time-lapse
images were taken at 5 min intervals. Cells transfected with the
Cx43shRNA migrated faster than their respective controls, further
confirming the close relationship between Cx43 expression levels
and the rate of migration in fibroblasts. Cx43shRNA-transfected
cells also displayed the same phenotype observed in Cx43asODN
treated fibroblasts, characterized by the formation of extensive
lamellipodia during migration.
(MOV)
Movie S3 Cx43-DN transfected cells migrate faster than
Cx43-WT or eGFP-transfected cells after wounding.
Fibroblasts were transiently transfected with bicistronic pIRES-
GFP expression vectors encoding Cx43-WT, Cx43-DN or eGFP
alone. The migration rates were monitored for 3 h and time-lapse
images were taken at 5 min intervals. Cells transfected with the
Cx43-DN migrated faster than their respective controls, and also
extended a large lamellipodial membrane protrusion at the leading
edge in the direction of the migration.
(MOV)
Movie S4 Actin dynamics is affected after silencing
Cx43. The effect of silencing of Cx43 on actin cytoskeleton
dynamics was analyzed after sequentially transfecting p.Sup or
Cx43shRNA-stable transfected fibroblasts with an RFP-actin
construct. Confocal time-lapse images were taken at intervals of
2 min for 1 K h after a scratch wounding confluent cultures.
(MOV)
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